Amyris, Inc. (NASDAQ:AMRS) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company.
Amyris, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased to $-0.39 in the quarter versus EPS of $-1.02 in the year-earlier quarter.
Revenue: Decreased 73.29% to $7.87 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Amyris, Inc. reported adjusted EPS loss of $0.39 per share. By that measure, the company missed the mean analyst estimate of $-0.38. It missed the average revenue estimate of $9.8 million.
Quoting Management: “With start up of our industrial-scale production plant in Brazil, Amyris has begun supplying customers with farnesene-derived products from our very own plant. Also, during the first quarter, we secured additional collaborations and partnerships to underpin our business strategy and took action to reduce our operating expenses,” said John Melo, President & CEO of Amyris.
Key Stats (on next page)…